BROCCOLI (CZ's Dog) sees 40.3% volatility in 24 hours: trading volume surges driven by Binance activity
Bitget Pulse2026/04/28 21:35Volatility Overview
In the past 24 hours, the price of BROCCOLI hit a low of $0.0154 and a high of $0.0216, currently quoted at $0.0214, with a price fluctuation of 40.3%. The 24-hour trading volume reached $12.3 million, with a market capitalization of about $15.6 million, and a trading volume/market cap ratio exceeding 70%.
Analysis of the Cause of Volatility
- The 24-hour trading volume surged to $12.3 million, with a net inflow of $19,700 on DEX and a net outflow of $33,300 on CEX, as active buying drove the rebound.
- In Binance spot USDT trading, BROCCOLI714 ranked second in meme coins’ 60-minute price gains (+3.18%), indicating active trading.
Market Views and Outlook
The mainstream sentiment among traders on X community is bullish. Finora AI analysis of the 1-hour chart shows the $0.0154 support is valid, with an upside target of $0.018, emphasizing the need to confirm a reversal pattern. Traders shared quick 4% gains on the 15-minute chart, expecting the rally to continue, but cautioning that a break below $0.0150 could turn the market bearish.
Note: This analysis is automatically generated by AI based on public data and on-chain monitoring, for information reference only.Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Moderna Q3 revenue up 29% year-on-year, far exceeding expectations, raises full-year revenue growth guidance to 15%-25% | Earnings Report Insight
Moderna's Q3 revenue increased by 29% year-on-year to $1.31 billion, with profits significantly exceeding expectations. The company raised its 2026 revenue growth guidance to 15%-25%. The ramp-up of next-generation COVID-19 and flu vaccines, along with international market expansion, has driven performance improvement. Phase III data for the personalized cancer vaccine has also shown positive progress. The company is simultaneously advancing cost reduction and pipeline R&D, with year-end cash expectations significantly raised.
Eli Lilly (LLY.US) "lowers its stance" and joins forces with former rival Hims (HIMS.US) to compete for the self-pay weight loss drug market
Eli Lilly is collaborating with Hims & Hers Health, leveraging the telehealth company’s large customer base to expand access to its blockbuster weight loss drugs and boost sales of medications, including its new oral weight loss drug Foundayo.
"Predicting Your Prediction" Intensifies Tech Stock Sell-off! After $2.3 Trillion Market Value Evaporates, Has the "Hot Money" Mechanical Selling Still Not Subsided?
The Nasdaq 100 Index fell by 6.4%, wiping out $2.3 trillion in market capitalization. The core reason behind this decline is concerns that a comprehensive victory by the Democratic Party could lead to stricter regulations on AI development. Systematic funds, which typically follow the stock market's trend and respond to price fluctuations and momentum signals, were thus forced to reduce their investments, accelerating the downturn. The selling pressure from systematic strategies may not be over yet; it is expected that in the coming days, portfolios targeting volatility will sell at least $50 billion worth of stocks.
The midterm election tears open the "abyss" of AI trading, facing a moment of reckoning for trillion-dollar capital expenditure narratives
For months, investors have been worried about a series of risks behind the AI (artificial intelligence) capital expenditure "money tree." This week, the market finally pressed the panic selling button.
Crypto prices
More
